rash was revealed. Birth history and family history were nonsignificant. The patient was not on any chronic medication. No history of seizure, psychosis or history of trauma at the site of blisters was present.
INTRODUCTION
B ullous systemic lupus erythematosus (BSLE) is a rare and distinct subtype of SLE, which occurs mostly in the third decade. It presents with specific clinical, histopathological, and immunological criteria. In children, however, it is very rare making it an uncommon differential diagnosis in case of a child presenting with tense bullae. year-old girl presented with multiple discrete clear fluid filled tense eruptions, erosions and healed dark patches over face, neck, abdomen, and extremities of 6 months duration. It started as perioral erosion and gradually involved other regions. The extremities were last to be involved. The eruptions were not limited to photo-exposed areas only. There is also associated complain of itching and photophobia but no complaint of fever or joint pain or history suggestive of Raynaud's phenomenon, or butterfly Investigations revealed normal complete blood count except for hemoglobin which was 9.8 g/dl. Erythrocyte sedimentation rate was 74 mm at 1 h and C-reactive protein was negative. Serum electrolytes and blood sugar was normal. Antinuclear antibody was positive in 1:100 dilution with coarse speckled pattern and anti-ds-DNA was 138 IU/ml (more than 75 IU/ml is considered positive). Among other antibody tests anti-ro-52 (2+), antiribosomal-p-protein (3+) and antihistone antibody (3+) was positive. Among blood immunoglobulins E (IgE) was mildly elevated (335 IU/ml). Urine routine and 24 h protein examination showed proteinuria (3+) and presence of granular cast. Her international normalized ratio and prothrombin time were within normal limits. However, the renal biopsy could not be performed because of the denial from the patient's family.
CASE REPORT

Skin biopsy from these bullous lesions revealed subepidermal cleft with a few neutrophil and eosinophils [Figures 3 and 4]. The infiltrates extends along eccrine
coils. Epidermal roof showed confluent necrosis in some areas. No mucin or viral inclusion body is seen. Direct immunofluorescence showed granular IgA and IgG deposition along dermo-epidermal junction with IgG > IgA. Also, perivascular IgG deposition was seen in the dermis. She was diagnosed to have BSLE. Indirect immunofluorescence was not done.
She was treated with prednisolone 2 mg/kg/day and dapsone 50 mg for her skin lesions. Significant improvement was seen within 2 weeks.
DISCUSSIONS
BSLE is a rare subepidermal blistering disease that occurs in a subset of patients with SLE. [1, 2] Cutaneous manifestations, though common in SLE patients BSLE is very rare (occurred <1% of patients with SLE). [3] [4] [5] BSLE patients present with a rapid, widespread development of tense fluid-filled bullous lesions apart from other features of SLE. Histologically, a subepidermal blister, with a predominantly neutrophilic dermal infiltrate and only occasional eosinophils, characterizes BSLE. Immunofluorescence examination may show deposition of IgG, IgA, C3, and C1q along dermo-epidermal junction. [5, 6] Apart from this typical clinical and histological presentation of BSLE, Camisa and Sharma proposed the diagnostic criteria for BSLE. It includes a diagnosis of SLE based on the following criteria of the American College of Rheumatology (ACR); vesicles and bullae mainly located on sun exposed areas; the histopathology is characterized by subepidermal bullae with microabscesses of neutrophils in the dermal papillae, similar to those found in dermatitis herpetiformis; and deposition of IgG, IgM or both, and often IgA in the basement membrane zone. [7] However, according to Gammon and Briggaman, [8] the minimum criteria for the diagnosis of BSLE are: (1) Meet the criteria for SLE of the American Rheumatism Association, (2) presence of nonscarring acquired bullous eruption on sun exposed areas, but not limited to these sites, (3) evidence of subepidermal blister with neutrophilic infiltrate in histology, (4) deposition of IgG, IgM, IgA, and C3 at the basement membrane zone, (5) circulating autoantibodies against Type VII collagen confirmed by salt-split skin indirect immunofluorescence or immunoprecipitation, and (6) presence of Ig deposits with anchoring fibrils/Type VII collagen by immunoelectron microscopy.
Although BSLE may exhibit any of the symptoms associated with SLE, the onset and course of blistering eruption do not necessarily parallel the activity of the systemic involvement. [8] Now in our case, the child is fulfilling the SLE criteria put forward by ACR (photosensitivity, antinuclear antibody, anti-ds-DNA antibody, 3+ proteinuria and granular cast in urine), and most other criteria suggested by both of that of Camisa and Sharma, as well as Gammon and Briggaman (nonscarring bullous starting from photo-exposed areas that is, face, subepidermal blister with neutrophilic infiltrate, IgG and IgA deposition along dermoepidermal junction). Inflammatory epidermolysis bullosa acquisitica was ruled out as the deposition was granular in nature. The renal involvement points toward lupus nephritis but could not be documented because the patient was not willing to undergo renal biopsy. Also, the circulating autoantibodies against collagen VII could not be measured due to the limitation of logistics.
BSLE is children is a very rare entity, only very few cases have been reported from India so far. [9] [10] [11] [12] [13] However, one reason may be difficulty in establishing the diagnosis due to limited laboratory facilities and other infrastructures in most part of India. We are reporting this case for its relatively rare occurrence in reported literature. Considering the systemic nature of SLE, BSLE should always be considered as a differential in case of children presenting with tense bullae even if it is not started from photo-exposed areas.
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